A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Completed · Phase 2 · Has a placebo group
Conditions studied: Diabetes Mellitus, Type 2
In brief
The purpose of this study was to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM). Bexagliflozin is an orally administered drug for the treatment of T2DM and is classified as a Sodium Glucose co-Transporter 2 (SGLT2) Inhibitor. This study was to enroll both treatment naive and those subjects previously treated with one oral hypoglycemic agent (OHA). Approximately 320 subjects eligible for randomization was to receive bexagliflozin tablets, 5, 10, 20 mg or placebo, once daily for 12 weeks in an outpatient setting.
Key facts
- Study ID
- NCT02390050
- Run by
- Theracos
- People needed
- 292
- Starts
- 2015-05-12
- Expected to finish
- 2016-06-03
- Last updated by the study team
- 2021-06-29
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Phoenix Medical Research Institute LLC — Peoria, Arizona, United States
- Advanced Arizona Clinical Research — Tucson, Arizona, United States
- Hope Clinical Research, LLC — Canoga Park, California, United States
- Catalina Research Institute — Chino, California, United States
- National Research Institute — Huntington Park, California, United States
- Long Beach Clinical Trials — Long Beach, California, United States
- Synergy San Diego — National City, California, United States
- Northern California Research — Sacramento, California, United States
- Artemis Institute for Clinical Research, LLC — San Diego, California, United States
- Infosphere Clinical Research, Inc — West Hills, California, United States
- M&O Clinical Research LLC — Fort Lauderdale, Florida, United States
- AGA Clinical Trials — Hialeah, Florida, United States
- Compass Research North — Leesburg, Florida, United States
- Sweet Hope Research Specialty, Inc — Miami Lakes, Florida, United States
- Sunshine Research Center — Opa-locka, Florida, United States
- Compass Research LLC — Orlando, Florida, United States
- Progressive Medical Research — Port Orange, Florida, United States
- PICR Clinic — Atlanta, Georgia, United States
- Sundance Clinical Research — St Louis, Missouri, United States
- Premier Research Ltd — Trenton, New Jersey, United States
- Regional Clinical Research, Inc — Endwell, New York, United States
- Calabash Medical Center — Calabash, North Carolina, United States
- Diabetes & Endocrinology Consultants PC — Morehead City, North Carolina, United States
- PMG Research of Salisbury — Salisbury, North Carolina, United States
- CTI Research — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.